Practice
Featured experience
InSilico Medicine HK$2.62 billion IPO
We advised InSilico Medicine on its IPO and HKEX listing
Mastercard $1.8 billion acquisition of BVNK
We are advising Mastercard on the transaction
Sycamore Partners up to $23.7 billion acquisition of Walgreens Boots Alliance
We are advising Sycamore Partners on the transaction
Comcast spinoff of select cable television networks
We are advising Comcast on the transaction
DexCom $1.25 billion convertible notes offering and capped call transactions
The 0.375% convertible senior notes are due 2028
Ocado Group acquisition of 6 River Systems
We are advising Ocado Group on the transaction
Cellular Biomedicine Group CAR-T collaboration and license agreement with Janssen
We are advising Cellular Biomedicine Group on the transaction
Advent International $2.25 billion Maxar Technologies acquisition financing
We advised the lenders on the facilities
Anglo American $900 million notes offering
The 5.500% senior notes are due 2033
Meta Platforms $8.5 billion senior notes offering
We advised Meta on the investment-grade debt offering
Invacare chapter 11 plan confirmed
We advised the prepetition term loan agent and escrow agent on the transaction
Crestview strategic investment in The Gersh Agency
We advised Crestview Partners on the transaction
Constellation Brands $750 million senior notes offering
The investment-grade notes are due 2033
MedSci Healthcare Holdings HK$608 million IPO
We advised MedSci on its IPO and HKEX listing